Posted AT 9:22 PM EDT on 27/04/08
Expensive colorectal cancer drug to go on sale
A pharmaceutical company that refused to market one of the world's most expensive cancer drugs due to a cost dispute will sell its medicine to Canadians after all – at a price lower than it had wanted.
Marc Osborne, spokesman for Bristol-Myers Squibb Canada, confirmed that cetuximab will be marketed some time this year at a price agreed to by the Patented Medicine Prices Review Board.
The full text of this article has 1027 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
Breakdown 
- Our mental health crisis
- Globe series tackles stigma, tells stories of Canadians
Child's View
- Focus on malaria
- Scenes from life in Liberia
Earlier discussion
slideshow
- Medical marijuna
- Alison Myrden's painful battle with MS
Features
- Confronting cancer
- Globe Series concludes with look at people who blaze trails
- Battling cancer
- Breast cancer death rates declining
-
Special report:
A day in the life
5In pictures
- Best position in bed
- How you sleep can make you feel better or worse
